Option Care Health (NASDAQ:OPCH) Sees Unusually-High Trading Volume – Here’s Why

Option Care Health, Inc. (NASDAQ:OPCH) saw unusually-high trading volume on Wednesday. 2,914,495 shares were traded during trading, an increase of 5% from the previous session’s volume of 2,766,312 shares. The stock last traded at $31.0050 and had previously closed at $31.00.

Trending Headlines about Option Care Health

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: Option Care Health agreed to be acquired by CD&R and McKesson in a transaction reportedly valuing the company at approximately $5.8 billion. The cash offer provides a clear valuation reference and potential support for OPCH shares through deal completion. Option Care Health agrees to $32.05 buyout by CD&R and McKesson
• Neutral Sentiment: JPMorgan reaffirmed a neutral rating while setting a $33 price target, modestly above the $32.05 transaction price. That target suggests limited incremental value beyond the announced offer unless deal expectations change. JPMorgan reaffirms neutral rating and $33 price target
• Neutral Sentiment: Recent analyst price-target activity reflects a shift from evaluating OPCH as a standalone company to assessing the probability and terms of the proposed buyout. Option Care Health analyst price targets
• Negative Sentiment: Barrington Research downgraded Option Care Health to market perform from outperform, following other recent rating cuts from Truist Financial and Citizens JMP to hold. The downgrades indicate reduced conviction in additional upside after the sharp deal-related move. Barrington Research downgrades Option Care Health
• Negative Sentiment: Several law firms, including Kahn Swick & Foti, Halper Sadeh and Ademi, are investigating whether the $32.05 offer fairly values the company and whether directors or insiders received benefits unavailable to public shareholders. These reviews introduce execution, litigation and deal-certainty risks. Kahn Swick & Foti Option Care Health investor alert

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. William Blair cut Option Care Health from an “outperform” rating to a “market perform” rating in a research report on Tuesday. Barrington Research lowered Option Care Health from an “outperform” rating to a “hold” rating in a research report on Wednesday. Stephens reissued an “equal weight” rating and issued a $24.00 price target (down from $30.00) on shares of Option Care Health in a research note on Friday, July 17th. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and boosted their price target for the stock from $28.00 to $32.05 in a report on Tuesday. Finally, Citizens Jmp cut shares of Option Care Health from a “market outperform” rating to a “hold” rating in a research report on Wednesday. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. Based on data from MarketBeat.com, Option Care Health currently has a consensus rating of “Hold” and an average price target of $29.70.

Option Care Health Stock Up 0.1%

The business has a fifty day simple moving average of $24.09 and a 200 day simple moving average of $23.59. The firm has a market cap of $4.65 billion, a price-to-earnings ratio of 23.35, a PEG ratio of 1.88 and a beta of 0.58. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. The business had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The business’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.41 earnings per share. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. As a group, equities analysts forecast that Option Care Health, Inc. will post 1.7 EPS for the current fiscal year.

Institutional Investors Weigh In On Option Care Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in OPCH. Arrowstreet Capital Limited Partnership raised its position in shares of Option Care Health by 6.2% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company’s stock valued at $135,355,000 after buying an additional 247,118 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Option Care Health by 0.9% during the first quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock worth $104,368,000 after acquiring an additional 36,208 shares during the last quarter. Southpoint Capital Advisors LP boosted its position in Option Care Health by 20.0% during the first quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock worth $96,912,000 after acquiring an additional 600,000 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. purchased a new stake in Option Care Health during the 1st quarter valued at about $70,287,000. Finally, Bank of America Corp DE grew its stake in Option Care Health by 14.6% during the 1st quarter. Bank of America Corp DE now owns 1,945,015 shares of the company’s stock valued at $52,360,000 after acquiring an additional 247,766 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.